Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-02

This notice is for the conclusion of agreements with pharmaceutical companies in the sense of § 130a para. 8 sentence 1 SGB V. The invitation to participate is directed only at pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs in the sense of § 4 para. 18 of the Medicinal Products Act. This is not an Open Procedure pursuant to § 15 VgV in conjunction with § 119 para. 3 GWB, but a publication of the invitation to conclude/join rebate agreements with conditions fixed and non-negotiable for all participants, including the amount of the rebate. There can be an unlimited number of pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs in the sense of § 4 para. 18 of the Medicinal Products Act as contracting partners.